Literature DB >> 26220191

A new variant of cytolethal distending toxin in a clinical isolate of Campylobacter hyointestinalis.

Worada Samosornsuk1,2, Kazumasa Kamei1,3, Noritoshi Hatanaka1, Takashi Taguchi1, Masahiro Asakura1, Srinuan Somroop1, Norihiko Sugimoto1, Wanpen Chaicumpa1,4, Shinji Yamasaki1.   

Abstract

Increasing numbers of Campylobacter hyointestinalis have been isolated from humans and animals with gastroenteritis, although the virulence mechanism of this species remains largely unknown. Here, we show that C. hyointestinalis isolated from a patient with diarrhoea in Thailand produced a novel variant of cytolethal distending toxin (CDT). Sequencing of a 13 965 bp genomic region of C. hyointestinalis carrying the genes coding for Ch-CDT revealed three ORFs of 798, 804 and 537 bp, which code for the Ch-CdtA, Ch-CdtB and Ch-CdtC subunits, respectively. The deduced amino acid sequence of Ch-CdtA showed ∼38.9 % homology with the CdtA of Campylobacter coli, but sequences of Ch-CdtB and Ch-CdtC were homologous to CdtB (65.7 %) and CdtC (33.1 %) of Campylobacter upsaliensis, respectively. Filter-sterilized sonic lysate of C. hyointestinalis demonstrated distension and death of HeLa cells by arresting the cell cycle at the G(2)/M phase and phosphorylation of host histone H2AX, a sensitive marker of DNA double-strand breaks. Rabbit antiserum raised against recombinant Ch-CdtB was not reactive against the recombinant CdtB protein of Campylobacter jejuni. A reconstituted Ch-CDT holotoxin prepared using each of the recombinant subunit proteins demonstrated distension and death of HeLa cells, suggesting that the C. hyointestinalis isolate indeed produced functionally active Ch-CDT. Furthermore, the immunological distinctiveness of the Ch-CDT produced by C. hyointestinalis and the increasing prevalence of the species in patients and animals with gastroenteritis suggest that this species may be an important emerging zoonotic pathogen.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26220191     DOI: 10.1099/jmm.0.000145

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

Review 1.  Pathogenomics of Emerging Campylobacter Species.

Authors:  Daniela Costa; Gregorio Iraola
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

2.  Campylobacter hyointestinalis Isolated from Pigs Produces Multiple Variants of Biologically Active Cytolethal Distending Toxin.

Authors:  Kazumasa Kamei; Noritoshi Hatanaka; Masahiro Asakura; Srinuan Somroop; Worada Samosornsuk; Atsushi Hinenoya; Naoaki Misawa; Shinsaku Nakagawa; Shinji Yamasaki
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

3.  Updating the genomic taxonomy and epidemiology of Campylobacter hyointestinalis.

Authors:  David A Wilkinson; Andrew J O'Donnell; Rukhshana N Akhter; Ahmed Fayaz; Hamish J Mack; Lynn E Rogers; Patrick J Biggs; Nigel P French; Anne C Midwinter
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

4.  A PCR-RFLP assay to detect and type cytolethal distending toxin (cdt) genes in Campylobacter hyointestinalis.

Authors:  Noritoshi Hatanaka; Kazumasa Kamei; Srinuan Somroop; Sharda Prasad Awasthi; Masahiro Asakura; Naoaki Misawa; Atsushi Hinenoya; Shinji Yamasaki
Journal:  J Vet Med Sci       Date:  2016-12-04       Impact factor: 1.267

5.  Campylobacter upsaliensis isolated from dogs produces high titer of cytolethal distending toxin.

Authors:  Srinuan Somroop; Noritoshi Hatanaka; Sharda Prasad Awasthi; Kentaro Okuno; Masahiro Asakura; Atsushi Hinenoya; Shinji Yamasaki
Journal:  J Vet Med Sci       Date:  2017-02-16       Impact factor: 1.267

6.  Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin-Induces Cell Cycle Arrest in a Glycogen Synthase Kinase (GSK)-3-Dependent Manner in Oral Keratinocytes.

Authors:  Bruce J Shenker; Lisa P Walker; Ali Zekavat; Jonathon Korostoff; Kathleen Boesze-Battaglia
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.